Accelerating drug development through the novel PLIMB epitope mapping technology
Location: United States
Employees: 1-10
Total raised: $8M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Tundra Ang... | tundraange... |
| - | Golden Ang... | goldenange... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.09.2025 | Seed | $8M | GREAT OAKS... |
Mentions in press and media 6
| Date | Title | Description |
| 24.09.2025 | Immuto Scientific Secures $8M, Unlocks New Era in Precision Drug Discovery | Immuto Scientific, a biotechnology pioneer, has significantly advanced its mission. The company closed an oversubscribed $8 million Seed 2 financing round. This critical capital fuels its proprietary AI-enabled structural surfaceomics platf... |
| 22.09.2025 | Immuto Scientific: $8 Million Raised For Advancing New Class Of Therapeutic Targets With Structural Surfaceomics | Immuto Scientific has closed an oversubscribed Seed 2 financing round, raising a total of $8 million. The company has also announced a collaboration with Daiichi Sankyo, a well-known global pharmaceutical company. Immuto is utilizing its un... |
| 18.09.2025 | Immuto Scientific Raises $8M in Seed 2 Financing | Immuto Scientific, a Madison, WI-based biotechnology company developing an AI‑enabled target discovery platform, raised $8M in Seed 2 funding. The round was led by DYDX, with participation from WARF Ventures, Gravity Fund, Great Oaks Ventur... |
| 12.10.2021 | Madison biotech startup Immuto Scientific raises $2.3 million to scale its drug discovery technology | - |
| - | Immuto Scientific | “Home” |
| - | Manage your consent preferences Madison biotech startup Immuto Scientific raises $2.3 million to scale its drug discovery technology | - |